Photobiomodulation therapy combined with static magnetic field is better than placebo in patients with fibromyalgia : a randomized placebo-controlled trial
BACKGROUND: Fibromyalgia is a syndrome characterized by generalized chronic pain and tenderness in specific areas. Photobiomodulation therapy (PBMT) using low-level laser therapy and/or light emitting diode therapy is an electrophysical agent that can be used alone or together with a static magnetic field (PBMT-sMF) to promote analgesia in several health conditions. Little evidence exists regarding the effects of using PBMT and PBMT-sMF in patients with fibromyalgia; this evidence is conflicting.
AIM: We aimed to investigate the effects of using PBMT-sMF versus a placebo on reduction of the degree-of-pain rating, impact of fibromyalgia, pain intensity, and satisfaction with treatment in patients with fibromyalgia.
DESIGN: A prospectively registered, monocentric, randomized placebo-controlled trial, with blinding of patients, therapists, and assessors, was performed.
SETTING: The study was conducted at the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil, between March and October 2020.
POPULATION: Ninety female patients with fibromyalgia were randomized to undergo either PBMT-sMF (N.=45) or placebo (N.=45) treatment.
METHODS: Patients from both groups received nine treatment sessions, three times a week, for 3 weeks. Clinical outcomes were collected at baseline, the end of treatment, and at the follow-up appointment 4 weeks post-treatment. The primary outcome was the degree-of-pain rating, measured by the reduction of the tender point count.
RESULTS: A decrease in the degree-of-pain rating was observed in patients allocated to the PBMT-sMF group, decreasing the number of tender points when compared to placebo group at the end of treatment (P<0.0001) and at the follow-up assessment (P<0.0001). Patients did not report any adverse events.
CONCLUSIONS: PBMT-sMF is superior to placebo, supporting its use in patients with fibromyalgia.
CLINICAL REHABILITATION IMPACT: PBMT-sMF might be considered an important adjuvant to the treatment regimens of patients with fibromyalgia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
European journal of physical and rehabilitation medicine - 59(2023), 6 vom: 17. Dez., Seite 754-762 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ribeiro, Neide F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 19.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.23736/S1973-9087.23.07928-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363398104 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363398104 | ||
| 003 | DE-627 | ||
| 005 | 20240119231911.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23736/S1973-9087.23.07928-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1264.xml |
| 035 | |a (DE-627)NLM363398104 | ||
| 035 | |a (NLM)37847246 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ribeiro, Neide F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Photobiomodulation therapy combined with static magnetic field is better than placebo in patients with fibromyalgia |b a randomized placebo-controlled trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 19.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Fibromyalgia is a syndrome characterized by generalized chronic pain and tenderness in specific areas. Photobiomodulation therapy (PBMT) using low-level laser therapy and/or light emitting diode therapy is an electrophysical agent that can be used alone or together with a static magnetic field (PBMT-sMF) to promote analgesia in several health conditions. Little evidence exists regarding the effects of using PBMT and PBMT-sMF in patients with fibromyalgia; this evidence is conflicting | ||
| 520 | |a AIM: We aimed to investigate the effects of using PBMT-sMF versus a placebo on reduction of the degree-of-pain rating, impact of fibromyalgia, pain intensity, and satisfaction with treatment in patients with fibromyalgia | ||
| 520 | |a DESIGN: A prospectively registered, monocentric, randomized placebo-controlled trial, with blinding of patients, therapists, and assessors, was performed | ||
| 520 | |a SETTING: The study was conducted at the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil, between March and October 2020 | ||
| 520 | |a POPULATION: Ninety female patients with fibromyalgia were randomized to undergo either PBMT-sMF (N.=45) or placebo (N.=45) treatment | ||
| 520 | |a METHODS: Patients from both groups received nine treatment sessions, three times a week, for 3 weeks. Clinical outcomes were collected at baseline, the end of treatment, and at the follow-up appointment 4 weeks post-treatment. The primary outcome was the degree-of-pain rating, measured by the reduction of the tender point count | ||
| 520 | |a RESULTS: A decrease in the degree-of-pain rating was observed in patients allocated to the PBMT-sMF group, decreasing the number of tender points when compared to placebo group at the end of treatment (P<0.0001) and at the follow-up assessment (P<0.0001). Patients did not report any adverse events | ||
| 520 | |a CONCLUSIONS: PBMT-sMF is superior to placebo, supporting its use in patients with fibromyalgia | ||
| 520 | |a CLINICAL REHABILITATION IMPACT: PBMT-sMF might be considered an important adjuvant to the treatment regimens of patients with fibromyalgia | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Leal-Junior, Ernesto C P |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Douglas S |e verfasserin |4 aut | |
| 700 | 1 | |a Demchak, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Machado, Caroline M |e verfasserin |4 aut | |
| 700 | 1 | |a Dias, Luana B |e verfasserin |4 aut | |
| 700 | 1 | |a DE Oliveira, Marcelo F |e verfasserin |4 aut | |
| 700 | 1 | |a Lino, Matheus M |e verfasserin |4 aut | |
| 700 | 1 | |a Rodrigues, Wesley D |e verfasserin |4 aut | |
| 700 | 1 | |a Santo, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a DE Barros, Carolina N |e verfasserin |4 aut | |
| 700 | 1 | |a Casalechi, Heliodora L |e verfasserin |4 aut | |
| 700 | 1 | |a Tomazoni, Shaiane S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of physical and rehabilitation medicine |d 2008 |g 59(2023), 6 vom: 17. Dez., Seite 754-762 |w (DE-627)NLM178672254 |x 1973-9095 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2023 |g number:6 |g day:17 |g month:12 |g pages:754-762 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23736/S1973-9087.23.07928-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2023 |e 6 |b 17 |c 12 |h 754-762 | ||